IP Library Granted Patent US 9,480,665
Granted Patent B2
US 9,480,665 · App. 14/922,362 · Granted Nov 1, 2016

Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups

Inventor: Nikhilesh Nihala Singh (Mill Valley, CA)
Assignee: ORPHOMED, INC.
A61K31/167A61K9/0053A61K9/20A61K31/137A61K31/485A61K45/06C07C217/64C07C217/70C07C233/25C07D489/02C07D489/08C07D489/12C07D519/00C07C2101/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,665
App. No.
14/922,362
Granted
Nov 1, 2016
Kind
B2
Abstract

Provided herein are methods for treating pain such as acute or chronic pain or fever in subject without risking hepatotoxicity. The subject may be at risk of hepatotoxicity if administrated an acetaminophen monomer. The method includes administering a pharmaceutical composition containing an acetaminophen dimer compound, wherein the phenolic hydroxyl groups of two acetaminophen compounds are linked via an ethylene spacer.

Claims (14)

1. A method of treating pain in a patient suffering from cirrhosis, liver cancer, hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, primary sclerosing cholangitis, Gilbert's syndrome, Budd-Chiari syndrome, transthyretin-related hereditary amyloidosis or acetaminophen poisoning, the method comprises administering to the patient a therapeutically effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier or excipient and an acetaminophen dimer compound having Formula (1):

or a pharmaceutically acceptable salt or solvate thereof.

2. The method of claim 1 , wherein the patient is an adult human patient.

3. The method of claim 1 , wherein the pharmaceutical composition further comprises a barbiturate, opioid, antihistamine, caffeine, diphenhydramine, dextromethorphan, pseudoephedrine or any combination thereof.

4. The method of claim 1 , wherein the pharmaceutical composition is administrated orally, rectally, sublingually, subcutaneously, intramuscularly, intravenously, transdermally, or transmucosally.

5. The method of claim 1 , wherein the therapeutically effective amount administered is about 500 mg to about 1000 mg.

6. The method of claim 5 , wherein the pharmaceutical composition is formulated as an oral tablet or extended release oral tablet.

7. The method of claim 1 , wherein the patient suffers from cirrhosis.

8. The method of claim 1 , wherein the patient suffers from liver cancer.

9. The method of claim 1 , wherein the patient suffers from hepatitis.

10. The method of claim 1 , wherein the patient suffers from alcoholic liver disease.

11. The method of claim 1 , wherein the patient suffers from non-alcoholic fatty liver disease.

12. The method of claim 1 , wherein the patient suffers from primary sclerosing cholangitis.

13. The method of claim 1 , wherein the patient suffers from acetaminophen poisoning.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2023
From: ORPHOMED, INC.
To: DIMERX, INC.
Reel/Frame 063610/0911 →
SECURITY INTEREST Recorded Jun 11, 2021
From: ORPHOMED, INC.
To: COMERICA BANK
Reel/Frame 056508/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: SINGH, NIKHILESH NIHALA
To: ORPHOMED, INC.
Reel/Frame 038881/0594 →
Continuity (5)
Continuation In Part 14697155 · Apr 27, 2015
Provisional Application 61985207 · Apr 28, 2014
Provisional Application 62101768 · Jan 9, 2015
Provisional Application 62176883 · Jan 9, 2015
Related Publication 20160045462A1 · Feb 18, 2016